They treated the prostate cancer cells with triptolide and found that triptolide significantly inhibited the proliferation of prostate cancer and was also able to reduce enhancer of zeste homolog 2 (EZH2) expression. The gene discussed is EZH2; the disease is prostate carcinoma.